These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 3942059)
1. Effects of isoproterenol and amiodarone and the role of exercise in initiation of circus movement tachycardia in the accessory atrioventricular pathway. Brugada P; Facchini M; Wellens HJ Am J Cardiol; 1986 Jan; 57(1):146-9. PubMed ID: 3942059 [TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy and electrophysiologic effects of intravenous and oral encainide in patients with accessory atrioventricular pathways and supraventricular arrhythmias. Abdollah H; Brugada P; Green M; Wehr M; Wellens HJ Am J Cardiol; 1984 Sep; 54(6):544-9. PubMed ID: 6433688 [TBL] [Abstract][Full Text] [Related]
3. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262 [TBL] [Abstract][Full Text] [Related]
4. Multiple circus movement tachycardias with multiple accessory pathways. Heddle WF; Brugada P; Wellens HJ J Am Coll Cardiol; 1984 Jul; 4(1):168-75. PubMed ID: 6736443 [TBL] [Abstract][Full Text] [Related]
5. Termination of circus movement tachycardia utilizing an accessory atrioventricular pathway by retrograde concealed penetration of the atrioventricular node through the bundle branch system. A mechanism of tachycardia termination in Wolff-Parkinson-White syndrome. Ross DL; Wiener I; Farre J; Bar FW; Vanagt EJ; Wellens HJ Am J Cardiol; 1981 May; 47(5):1173-7. PubMed ID: 7223665 [TBL] [Abstract][Full Text] [Related]
6. Cycle length alternation in circus movement tachycardia using an atrioventricular accessory pathway. A study of the role of the atrioventricular node using a computer model of tachycardia. Ross DL; Dassen WR; Vanagt EJ; Brugada P; Bär FW; Wellens HJ Circulation; 1982 May; 65(5):862-8. PubMed ID: 7074748 [TBL] [Abstract][Full Text] [Related]
7. Effect of isoproterenol on the anterograde refractory period of the accessory pathway in patients with the Wolff-Parkinson-White syndrome. Wellens HJ; Brugada P; Roy D; Weiss J; Bär FW Am J Cardiol; 1982 Jul; 50(1):180-4. PubMed ID: 7090999 [TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide. Helmy I; Scheinman MM; Herre JM; Sharkey H; Griffin JC J Am Coll Cardiol; 1990 Dec; 16(7):1649-55. PubMed ID: 2123908 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway. Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Wellens HJ; Brugada P; Abdollah H; Dassen WR Circulation; 1984 Jan; 69(1):120-4. PubMed ID: 6689635 [TBL] [Abstract][Full Text] [Related]
11. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome. Wellens HJ; Brugada P; Abdollah H Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833 [TBL] [Abstract][Full Text] [Related]
12. Effects of oral amiodarone on rate-dependent changes in refractoriness in patients with Wolff-Parkinson-White syndrome. Brugada P; Wellens HJ Am J Cardiol; 1985 Nov; 56(13):863-6. PubMed ID: 4061328 [TBL] [Abstract][Full Text] [Related]
13. Incessant reciprocating atrioventricular tachycardia. Factors playing a role in the mechanism of the arrhythmia. Brugada P; Vanagt EJ; Bar FW; Wellens HJ Pacing Clin Electrophysiol; 1980 Nov; 3(6):670-7. PubMed ID: 6161348 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias. Waleffe A; Dufour A; Aymard MF; Kulbertus H Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182 [TBL] [Abstract][Full Text] [Related]
15. Role of intravenous isoproterenol in the electrophysiologic induction of atrioventricular node reentrant tachycardia in patients with dual atrioventricular node pathways. Huycke EC; Lai WT; Nguyen NX; Keung EC; Sung RJ Am J Cardiol; 1989 Nov; 64(18):1131-7. PubMed ID: 2479251 [TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic characteristics of diverse accessory pathway locations of antidromic reciprocating tachycardia. Luria DM; Chugh SS; Munger TM; Friedman PA; Rea RF; Packer DL; Jahangir A; Hammill SC; Shen WK Am J Cardiol; 2000 Dec; 86(12):1333-8. PubMed ID: 11113408 [TBL] [Abstract][Full Text] [Related]
17. Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation. Matsuda H; Konishi T; Matsuyama E; Tamamura T; Kawai C Jpn Circ J; 1981 Oct; 45(10):1138-46. PubMed ID: 7299993 [TBL] [Abstract][Full Text] [Related]
18. Chronic effects of amiodarone in patients with refractory ventricular tachycardia. Saksena S; Rothbart ST; Cappello G Int J Cardiol; 1983 Jun; 3(3):339-52. PubMed ID: 6347914 [TBL] [Abstract][Full Text] [Related]
19. Effect of isoproterenol on accessory pathways without overt retrograde conduction. Li HG; Yee R; Klein GJ J Cardiovasc Electrophysiol; 1995 Mar; 6(3):170-3. PubMed ID: 7620642 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia. Manz M; Steinbeck G; Lüderitz B Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]